Published in Hepatology on November 01, 1996
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut (1999) 1.49
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep (2013) 1.17
High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol (2001) 1.01
HCV status knowledge and risk behaviours amongst intravenous drug users. Eur J Epidemiol (2000) 0.96
Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol (2001) 0.94
Dual chronic hepatitis B virus and hepatitis C virus infection. Hepatol Int (2009) 0.85
Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC Public Health (2014) 0.84
Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City. Am J Public Health (2002) 0.78
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet (2001) 35.17
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature (1997) 9.98
Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol (1989) 3.59
HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A (1998) 3.35
NIH conference. Hepatocellular carcinoma. Ann Intern Med (1988) 2.94
A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity. Am J Gastroenterol (1990) 2.59
The role of liver biopsy in chronic hepatitis C. Hepatology (2001) 2.47
Measurements of iron status in patients with chronic hepatitis. Gastroenterology (1992) 2.22
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol (1998) 2.13
The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer (2000) 2.12
Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A (1997) 2.06
Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology (1990) 2.06
Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A (1997) 2.03
Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C. J Viral Hepat (2007) 1.89
Hereditary hemochromatosis: pathogenesis and clinical features of a common disease. Am J Gastroenterol (1989) 1.87
Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest (1983) 1.74
Hepatic iron and nonalcoholic fatty liver disease. Hepatology (1999) 1.70
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A (1999) 1.66
Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci U S A (2001) 1.65
Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci U S A (1997) 1.61
Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A (1999) 1.60
Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical. J Neurochem (1996) 1.58
Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A (2000) 1.54
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology (1995) 1.51
Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol (2000) 1.50
The utility of the 13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther (2003) 1.43
Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis. Dig Dis Sci (1998) 1.41
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.40
Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy. Am J Gastroenterol (1991) 1.39
Can the need for a physician as part of the pediatric transport team be predicted? A prospective study. Crit Care Med (1992) 1.37
Chemical peeling as adjuvant therapy for facial neurotic excoriations. J Am Acad Dermatol (1994) 1.37
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant (2004) 1.30
Complementary and alternative medicine in chronic liver disease. Hepatology (2001) 1.29
Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology (1996) 1.28
Wilson's disease, presenting as chronic active hepatitis. Gastroenterology (1978) 1.26
Esophageal perforation due to nasogastric intubation. Am J Gastroenterol (1990) 1.25
Iron overload: causes and consequences. Annu Rev Nutr (1987) 1.23
When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology (1986) 1.23
Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.22
Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology (1995) 1.20
Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology (1983) 1.16
Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology (1992) 1.14
Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology (1994) 1.14
Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma. Cancer Res (1992) 1.13
Spectrum of hepatitis E virus infection in India. J Med Virol (1994) 1.12
Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology (1994) 1.10
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology (2000) 1.09
Cryptosporidial enteritis in a homosexual male with an acquired immunodeficiency syndrome. Cleve Clin Q (1983) 1.08
Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer (2003) 1.05
Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology (1985) 1.04
Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies. Gastroenterology (1975) 1.04
Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Hepatology (2001) 1.04
Nonalcoholic steatohepatitis. Med Clin North Am (1996) 1.03
Vitamin A-poor lipocytes: a novel desmin-negative lipocyte subpopulation, which can be activated to myofibroblasts. Am J Physiol (1995) 1.03
Pathology of dietary carbonyl iron overload in rats. Lab Invest (1987) 1.02
Role of the hepatocyte microtubular system in the excretion of bile salts and biliary lipid: implications for intracellular vesicular transport. J Lipid Res (1988) 1.02
Enhanced activity of the free radical producing enzyme xanthine oxidase in hypoxic rat liver. Regulation and pathophysiologic significance. J Clin Invest (1991) 1.02
Molecular aspects of iron absorption and HFE expression. Gastroenterology (2001) 1.02
Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology (1995) 1.01
Retinal abnormalities associated with anemia. Arch Ophthalmol (1983) 1.01
Neurological complications following liver transplantation. Ann Neurol (1992) 1.01
Subcellular distribution and regulation of hepatic bilirubin UDP-glucuronyltransferase. J Biol Chem (1984) 1.00
Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice. Proc Natl Acad Sci U S A (2001) 0.99
Membrane lipid composition and vesicle size modulate bilirubin intermembrane transfer. Evidence for membrane-directed trafficking of bilirubin in the hepatocyte. J Biol Chem (1994) 0.99
Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction. Am J Pathol (1998) 0.99
Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures. Epilepsia (2000) 0.98
Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical. Am J Physiol (1989) 0.98
Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology (1994) 0.98
Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl (2001) 0.98
The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology (1997) 0.97
Hepatic microsomal glucuronidation of bilirubin is modulated by the lipid microenvironment of membrane-bound substrate. J Biol Chem (1986) 0.97
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir. Aliment Pharmacol Ther (2015) 0.97
Neurologic complications of liver transplantation. Transplantation (1988) 0.97
Kinetics of bilirubin transfer between serum albumin and membrane vesicles. Insight into the mechanism of organic anion delivery to the hepatocyte plasma membrane. J Biol Chem (1995) 0.97
Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant (2004) 0.97
Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes. Haematologica (2000) 0.96
Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med (1995) 0.96
Portopulmonary hypertension and the liver transplant candidate. Transplantation (1999) 0.96
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol (2013) 0.96
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res (2000) 0.95
Spontaneous rupture of the liver upon revascularization during transplantation. Transplantation (2000) 0.95
Sarcoidosis of the eyelid skin. Can J Ophthalmol (1990) 0.94
Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndrome. Gut (1976) 0.94
Sex differences in hepatic uptake of long chain fatty acids in single-pass perfused rat liver. J Lipid Res (1981) 0.94
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst (1999) 0.94
Mechanism of the spontaneous transfer of unconjugated bilirubin between small unilamellar phosphatidylcholine vesicles. Biochemistry (1992) 0.94
Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration. J Lab Clin Med (1987) 0.94
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol (2006) 0.93
Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity. Am J Physiol (1994) 0.93
Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Am J Gastroenterol (1998) 0.93
Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C. Am J Gastroenterol (2001) 0.92
Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. Br Med J (1977) 0.92
Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Bone Marrow Transplant (2005) 0.92
The role of albumin in hepatic uptake processes. Prog Liver Dis (1982) 0.91